权益分类	功能权益	普通用户	{{item.name}}会员
{{category.name}}	{{benefitItem.name}}

Ovarian Epithelial Cancer Progenitor Cell Population

卵巢上皮癌祖细胞群

基本信息

批准号：
10524246
负责人：
XiangXi Mike Xu
金额：
$ 4.65万
依托单位：
UNIVERSITY OF MIAMI SCHOOL OF MEDICINE
依托单位国家：
美国
项目类别：
财政年份：
2018
资助国家：
美国
起止时间：
2018-05-10 至 2024-04-30
项目状态：
已结题

来源：
https://reporter.nih.gov/project-details/10524246
关键词：
AMHR2 gene Antral Basic Science Biology Birth Cancer Biology Candidate Disease Gene Carcinoma Cell model Cells Coculture Techniques Development Devices Embryo Embryonic Development Endocrine Environment Epithelial Epithelial Cells Epithelial ovarian cancer Event Female Gene Chips Germ Cells Goals Growth Homeostasis Human Implant Investigation LGR5 gene Lesion MT3 gene Malignant Neoplasms Malignant neoplasm of ovary Mammalian Oviducts Menopause Methods Modeling Molecular Mosaicism Mus Mutation Organ Ovarian Ovarian Follicle Ovarian Granulosa Cell Ovarian Serous Adenocarcinoma Ovarian Tissue Ovarian aging Ovary Ovulation Pathway interactions Pharmaceutical Preparations Physiology Play Population Production Property Proteomics Publishing Regulation Reproductive History Research Research Project Grants Role Serous Study models Surface TP53 gene Testing Testis Tissues Transgenic Organisms Tumor Suppression Tumor-Derived Variant White Spots Woman Work base cancer risk cancer stem cell cell population study clinical application design epithelial stem cell experimental study fimbria granulosa cell human tissue insight male mouse model mullerian-inhibiting hormone mutant mouse model ovarian neoplasm paracrine progenitor receptor reproductive response screening stem cell model stem cell population stem cells stem-like cell tumor

项目摘要

ABSTRACT This research project is to study a putative ovarian cancer progenitor and stem cell population, and the impact of menopause on the potential for the cells to undergo transformation. We have made a surprising discovery that a mosaic subpopulation of ovarian and fallopian tube epithelial cells is derived from MISR2 (Mullerian inhibitory substance receptor type 2) lineage. Furthermore these cells of MISR2-derived subpopulation have high proliferative potential and develop epithelial tumors in mice that ovarian follicles are depleted. Based on our recent studies (published and unpublished), we have developed a unique hypothesis that the MISR2-derived subpopulation of ovarian and fallopian tube epithelial cells are epithelial stem cells and precursors of ovarian cancer. Additionally, these cells are responsive to suppression by MIS/AMH (Mullerian inhibitory substance/anti-Mullerian hormone) produced by granulosa cells of ovarian follicles. We plan to test these ideas by studying the MISR2-containing ovarian and fallopian tube epithelial cells for their growth and stem cell properties, and also study their response to the MIS factor, in both mouse models and human cells and tissues. Previously, we found that ovarian follicles and granulosa cells produce a growth inhibitory factor(s) towards ovarian epithelial cells in culture, and provided evidence that MIS is a strong candidate for the factor. We will seek to identify the factor(s) produced by granulosa cells using a transwell device for co-culturing of ovarian and fallopian tube epithelial cells with granulosa cells, and to verify if MIS contributes to part or all of the inhibitory activity. Experiments designed are also to test the roles of the MIS/MISR2 paracrine/endocrine pathway in maintaining the tissues homeostasis of the ovarian and fallopian tube environment, and in tumor suppression, as summarized in two main aims. The first major aim is to characterize the MISR2-positive cells to determine if these cells are progenitor/stem cell like, and precursors for ovarian cancer. The second major aim is to identify the tumor suppressing factor(s) produced by follicles/granulosa cells and to study its regulation of ovarian epithelial cells in ovarian tissue homeostasis. Granulosa cell-derived MIS will be tested as a strong candidate of the follicle-derived factor. The experiments will use human ovarian cancer tissues, primary and established cells, and transgenic mutant mouse models to study molecular mechanisms and relevance to human ovarian tissue and cancer. The findings and conclusions from the study of cell and mouse models will be verified in human normal and cancer tissues. If successful, our work will solve the long-standing puzzle for the reason why ovarian cancer risk is high in menopausal women. The research will also gain insight into an ovarian epithelial and cancer stem cell population, and will yield a substantial new advance in ovarian cancer biology.

摘要